Insider Trades of BAY CITY CAPITAL LLC Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date ▲ Type Tran OwnerType Shares Traded Last Price Shares Held
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 05/17/2013 Form 4 Sell direct 129,455 22.69 43,444
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 05/20/2013 Form 4 Sell direct 2,000 22.24 43,407
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 05/28/2013 Form 4 Sell direct 12,000 21.08 43,183
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 05/30/2013 Form 4 Sell direct 5,366 21 43,083
EPIZYME, INC. Beneficial Owner (10%) 06/05/2013 Form 4 Acquisition (Non Open Market) indirect 3,492,063 0 3,492,063
EPIZYME, INC. Beneficial Owner (10%) 06/05/2013 Form 4 Buy indirect 166,666 15 7,314,341
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 06/27/2013 Form 4 Dividend Reinvestment direct 10,000 22.5333 43,107
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 06/28/2013 Form 4 Dividend Reinvestment direct 15,860 22.5132 42,810
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 07/03/2013 Form 4 Dividend Reinvestment direct 13,300 22.5049 42,561
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 07/05/2013 Form 4 Dividend Reinvestment direct 100 22.5 42,559
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 07/08/2013 Form 4 Dividend Reinvestment direct 8,900 22.5 42,393
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 07/09/2013 Form 4 Dividend Reinvestment direct 1,100 22.5036 42,372
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 07/10/2013 Form 4 Dividend Reinvestment direct 51,830 22.3481 41,403
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 07/17/2013 Form 4 Dividend Reinvestment direct 87,000 26 39,726
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 07/18/2013 Form 4 Dividend Reinvestment direct 3,703 26 39,657
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 07/19/2013 Form 4 Dividend Reinvestment direct 5,200 26.69 39,560
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 10/18/2013 Form 4 Dividend Reinvestment direct 200,000 26 35,820
EPIZYME, INC. Beneficial Owner (10%) 02/10/2014 Form 4 Sell indirect 466,667 29.25 6,392,851
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/08/2014 Form 4 Sell direct 675,000 6.6201 4,963,087
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/11/2014 Form 4 Sell direct 31,600 6.902 4,931,487